{
    "title": "Novo Nordisk to start late-stage trial of semaglutide to treat Alzheimer's",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-9059711/Novo-Nordisk-moves-semaglutide-drug-phase-3a-trial-Alzheimers.html",
    "date": "2020-12-16",
    "keywords": [
        "semaglutide",
        "drug",
        "novo",
        "trial",
        "effect",
        "glp1",
        "function",
        "copenhagen",
        "drugmaker",
        "nordisk",
        "latestage",
        "treatment",
        "gmt",
        "news",
        "analyst",
        "soeren",
        "move",
        "signal",
        "confidence",
        "success",
        "highrisk",
        "study",
        "analogue",
        "production",
        "form",
        "disease",
        "need",
        "evidence",
        "role",
        "officer",
        "statement",
        "company",
        "neuroinflammation",
        "cognition",
        "memory",
        "reduction",
        "development",
        "dementia",
        "patient",
        "group",
        "phase",
        "iiia",
        "efficacy",
        "safety",
        "milligram",
        "dose",
        "half",
        "companys",
        "pillversion",
        "skydsgaard",
        "editing",
        "hardcastle",
        "mark",
        "potter"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}